SPONSOR
AHS Cancer Control Alberta
Total Trials
6
Recruiting
6
Phases
EARLY_Phase 1, Phase 1, Phase 2, Phase 2
Conditions studied: GlioblastomaRecurrent DiseaseRecurrent GlioblastomaCancerCarcinoma, NeuroendocrineAutologous Stem Cell TransplantPancreatic CancerHepatocellular CancerBiliary Tract CancerCholangiocarcinoma
AHS Cancer Control Alberta is a clinical research sponsor with 6 registered studies on ClinicalTrials.gov, of which 6 are actively recruiting participants. Research covers conditions including Glioblastoma, Recurrent Disease, Recurrent Glioblastoma, Cancer.
The trial portfolio spans EARLY_Phase 1, Phase 1, Phase 2, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — AHS Cancer Control Alberta
How many clinical trials has AHS Cancer Control Alberta sponsored?
ClinicalMetric currently tracks 6 clinical trials sponsored by AHS Cancer Control Alberta, of which 6 are actively recruiting participants. These trials cover conditions including Glioblastoma, Recurrent Disease, Recurrent Glioblastoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does AHS Cancer Control Alberta research focus on?
AHS Cancer Control Alberta clinical trials span Glioblastoma, Recurrent Disease, Recurrent Glioblastoma, Cancer, Carcinoma, Neuroendocrine, and additional conditions. The research pipeline includes EARLY_Phase 1, Phase 1, Phase 2, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a AHS Cancer Control Alberta clinical trial?
To participate in a AHS Cancer Control Alberta trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all AHS Cancer Control Alberta trials with current recruitment status updated daily.
Clinical Trials by AHS Cancer Control Alberta
NCT05432518 EARLY_Phase 1
Recruiting
Pilot Trial for Treatment of Recurrent Glioblastoma
Glioblastoma
NCT05413473 Phase 1, Phase 2
Recruiting
Northern Alberta Linac-MR Image-Guided Radiotherapy (Northern LIGHTs-2)
Cancer
NCT01876771 Phase 2
Recruiting
A Trial to Assess the Safety and Effectiveness of Lutetium-177 Octreotate Therapy in Neuroendocrine Tumours
Carcinoma, Neuroendocrine
NCT04358913
Recruiting
MR Imaging Study Using the Northern Alberta Linac-MR (Northern LIGHTs - 1)
Cancer
NCT05358262 Phase 2
Recruiting
High Heated Humidity in Stem Cell Transplant
Autologous Stem Cell Transplant
NCT05451043 Phase 2
Recruiting
Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)
Pancreatic Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology